These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 20828749

  • 1. The stage dependent changes in NK cell activity and the expression of activating and inhibitory NK cell receptors in melanoma patients.
    Mirjačić Martinović K, Konjević G, Babović N, Inić M.
    J Surg Res; 2011 Dec; 171(2):637-49. PubMed ID: 20828749
    [Abstract] [Full Text] [Related]

  • 2. Distribution of several activating and inhibitory receptors on CD3(-)CD56(+) NK cells in regional lymph nodes of melanoma patients.
    Vuletić A, Jurišić V, Jovanić I, Milovanović Z, Nikolić S, Konjević G.
    J Surg Res; 2013 Aug; 183(2):860-8. PubMed ID: 23522458
    [Abstract] [Full Text] [Related]

  • 3. Biomarkers of suppressed natural killer (NK) cell function in metastatic melanoma: decreased NKG2D and increased CD158a receptors on CD3-CD16+ NK cells.
    Konjević G, Mirjacić Martinović K, Jurisić V, Babović N, Spuzić I.
    Biomarkers; 2009 Jun; 14(4):258-70. PubMed ID: 19489688
    [Abstract] [Full Text] [Related]

  • 4. In vitro increased natural killer cell activity of metastatic melanoma patients with interferon-α alone as opposed to its combination with 13-cis retinoic acid is associated with modulation of NKG2D and CD161 activating receptor expression.
    Konjevic G, Mirjacic-Martinovic K, Vuletic A, Babovic N.
    J BUON; 2012 Jun; 17(4):761-9. PubMed ID: 23335538
    [Abstract] [Full Text] [Related]

  • 5. Decreased expression of NKG2D, NKp46, DNAM-1 receptors, and intracellular perforin and STAT-1 effector molecules in NK cells and their dim and bright subsets in metastatic melanoma patients.
    Mirjačić Martinović KM, Babović NLj, Džodić RR, Jurišić VB, Tanić NT, Konjević GM.
    Melanoma Res; 2014 Aug; 24(4):295-304. PubMed ID: 24769842
    [Abstract] [Full Text] [Related]

  • 6. Expansion of functionally skewed CD56-negative NK cells in chronic hepatitis C virus infection: correlation with outcome of pegylated IFN-alpha and ribavirin treatment.
    Gonzalez VD, Falconer K, Björkström NK, Blom KG, Weiland O, Ljunggren HG, Alaeus A, Sandberg JK.
    J Immunol; 2009 Nov 15; 183(10):6612-8. PubMed ID: 19846870
    [Abstract] [Full Text] [Related]

  • 7. Natural killer receptors on CD8 T cells and natural killer cells from different HLA-C phenotypes in melanoma patients.
    Campillo JA, Martínez-Escribano JA, Moya-Quiles MR, Marín LA, Muro M, Guerra N, Parrado A, Campos M, Frías JF, Minguela A, García-Alonso AM, Alvarez-López MR.
    Clin Cancer Res; 2006 Aug 15; 12(16):4822-31. PubMed ID: 16914567
    [Abstract] [Full Text] [Related]

  • 8. In-vitro IL-2 or IFN-α-induced NKG2D and CD161 NK cell receptor expression indicates novel aspects of NK cell activation in metastatic melanoma patients.
    Konjević G, Mirjačić Martinović K, Vuletić A, Babović N.
    Melanoma Res; 2010 Dec 15; 20(6):459-67. PubMed ID: 20938360
    [Abstract] [Full Text] [Related]

  • 9. Evidence for natural killer cell-mediated protection from metastasis formation in uveal melanoma patients.
    Maat W, van der Slik AR, Verhoeven DH, Alizadeh BZ, Ly LV, Verduijn W, Luyten GP, Mulder A, van Hall T, Koning F, Jager MJ, van Bergen J.
    Invest Ophthalmol Vis Sci; 2009 Jun 15; 50(6):2888-95. PubMed ID: 19234348
    [Abstract] [Full Text] [Related]

  • 10. A rapid method for assessment of natural killer cell function after multiple receptor crosslinking.
    Al-Hubeshy ZB, Coleman A, Nelson M, Goodier MR.
    J Immunol Methods; 2011 Mar 07; 366(1-2):52-9. PubMed ID: 21281644
    [Abstract] [Full Text] [Related]

  • 11. Low expression of CD161 and NKG2D activating NK receptor is associated with impaired NK cell cytotoxicity in metastatic melanoma patients.
    Konjević G, Mirjacić Martinović K, Vuletić A, Jović V, Jurisić V, Babović N, Spuzić I.
    Clin Exp Metastasis; 2007 Mar 07; 24(1):1-11. PubMed ID: 17295095
    [Abstract] [Full Text] [Related]

  • 12. Expression of killer immunoglobulin-like receptors on peripheral blood NK cell subsets of women with recurrent spontaneous abortions or implantation failures.
    Ntrivalas EI, Bowser CR, Kwak-Kim J, Beaman KD, Gilman-Sachs A.
    Am J Reprod Immunol; 2005 May 07; 53(5):215-21. PubMed ID: 15833099
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of activatory and inhibitory natural killer cell receptors in non-segmental vitiligo: a flow cytometric study.
    Basak PY, Adiloglu AK, Koc IG, Tas T, Akkaya VB.
    J Eur Acad Dermatol Venereol; 2008 Aug 07; 22(8):970-6. PubMed ID: 18482314
    [Abstract] [Full Text] [Related]

  • 14. Age-related changes in natural killer cell receptors from childhood through old age.
    Almeida-Oliveira A, Smith-Carvalho M, Porto LC, Cardoso-Oliveira J, Ribeiro Ados S, Falcão RR, Abdelhay E, Bouzas LF, Thuler LC, Ornellas MH, Diamond HR.
    Hum Immunol; 2011 Apr 07; 72(4):319-29. PubMed ID: 21262312
    [Abstract] [Full Text] [Related]

  • 15. Fine characterization of intrahepatic NK cells expressing natural killer receptors in chronic hepatitis B and C.
    Bonorino P, Ramzan M, Camous X, Dufeu-Duchesne T, Thélu MA, Sturm N, Dariz A, Guillermet C, Pernollet M, Zarski JP, Marche PN, Leroy V, Jouvin-Marche E.
    J Hepatol; 2009 Sep 07; 51(3):458-67. PubMed ID: 19596474
    [Abstract] [Full Text] [Related]

  • 16. Phenotype and function of natural killer cells in systemic lupus erythematosus: excess interferon-γ production in patients with active disease.
    Hervier B, Beziat V, Haroche J, Mathian A, Lebon P, Ghillani-Dalbin P, Musset L, Debré P, Amoura Z, Vieillard V.
    Arthritis Rheum; 2011 Jun 07; 63(6):1698-706. PubMed ID: 21370226
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cell surface expression of activating receptors and co-receptors on peripheral blood NK cells in systemic autoimmune diseases.
    Puxeddu I, Bongiorni F, Chimenti D, Bombardieri S, Moretta A, Bottino C, Migliorini P.
    Scand J Rheumatol; 2012 Aug 07; 41(4):298-304. PubMed ID: 22632143
    [Abstract] [Full Text] [Related]

  • 19. Favorable in vitro effects of combined IL-12 and IL-18 treatment on NK cell cytotoxicity and CD25 receptor expression in metastatic melanoma patients.
    Mirjačić Martinović K, Babović N, Džodić R, Jurišić V, Matković S, Konjević G.
    J Transl Med; 2015 Apr 14; 13():120. PubMed ID: 25889680
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.